Corestemchemon (166480.KQ) Stock Price

Corestemchemon Price

CLOSED
1,625.00
​
Market closed

Over the last 13 years Corestemchemon grew revenue by 60.8% annually, reaching 20.16 B KRW. For Corestemchemon, the net margin of -133.1% is down versus -23.1% a few years ago.

Corestemchemon stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corestemchemon business model & stock analysis

CORESTEMCHEMON, Inc. engages in the development and distribution of gene therapy products. The company is headquartered in Seoul, Seoul. The company went IPO on 2015-06-26. The firm operates its business through two segments. The Non-clinical Contract Research Organization (CRO) Business segment is engaged in the provision of research and development services such as toxicity (safety) verification and drug efficacy (efficacy) verification in the non-clinical stage. The Cell Therapy Business segment is engaged in the development, production and sale of Lou Gehrig's disease treatments such as Neuronata-R.

Frequently asked questions about Corestemchemon

Converted at the current exchange rate, the Corestemchemon share trades at 1.08 EUR (1,625.00 KRW).

The revenue cannot currently be calculated for Corestemchemon.

The profit cannot currently be calculated for Corestemchemon.

The P/E ratio cannot be calculated for Corestemchemon at the moment.

The P/S cannot be calculated for Corestemchemon currently.

The Eulerpool Quality Score for Corestemchemon is 1/10.

The ISIN of Corestemchemon is KR7166480004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Corestemchemon is 166480.KQ. The ticker symbol is used to trade Corestemchemon shares on the stock exchange.

Fair ValueTerminal
1,527.50 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website corestem.com
Country
South Korea
Currency
KRW
Initial public offering
Jun 26, 2015
ISIN
KR7166480004
Cusip
Y1R6E7108
Market capitalization
44.38 B KRWLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.80
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-40.06 %
Last updated Nov 11, 2026, 5:40 PM

Corestemchemon Peer Group

Corestemchemon FIGI

166480:KQ · BBG008SHM7S4166480:KS · BBG008SHM7N9